debatesinoncology

Saudi Society of internal Medicine and King Abdullah Medical City in cooperation with AMAAC

Saudi Interna Medicine Society and King Abdulaziz University-
Saudi Arabia in Cooperation With AMAAC

Debates in Oncology 2023

WELCOME MESSAGE

Dear Colleague,
It is my pleasure to welcome you all in the King Abdullah Medical City annual conference. This year the conference will cover several important hot topics related to the management of different cancer subtypes in our region, including recent advances in Medical Oncology, Radiation Oncology, pathology and palliative care.
We hope this meeting will bring us all up to date knowledge in the field of oncology with very interesting scientific program that focus on the debates in cancer management. Distinguished national, regional speakers and international speakers will join us on this conference and will share their experience with us.
I hope this meeting will be an excellent educational experience and I wish you would enjoy the scientific sessions. We are sure that your active participation will add to the value of this important oncology conference.
Finally, I would like to express my deep thanks to the organizing and scientific committee.
Thank You.

Dr. Khalofa Alghamdi

Director of Oncology Center – King Abdullah Medical City

Target Audience

DEBATES IN ONCOLOGY

TARGET GROUPS

Medical oncology

Radiation oncology

Palliative Care

Oncology Nurses

Pharmacists

Surgical Oncology

speakers Debates in Oncology 2022

Debates in Oncology 2022

Prof. Hafez Ghanem

Dr. Omalkhair Abulkhair

Dr. Meteb Alfoheidi

Dr. Fahed Ibn Shamsa

Debates in Oncology 2022

29 - 30 September

1 October

attendees

speakers

Topic

days

LISTEN TO THE

Scientific Program

09:00-09:40

Session I: Colorectal Cancer Adjuvant Therapy after Metastatectomy/local therapy Yes/No

Panel: Shouki Bazarbashi, Ashwaq Aolayan, Hani Eltaani, Marwan AlHajeili , Ruaa Shafi, Kakil Rasoul, Kanan Alshammari, Ahmad Antar

Moderator: Mervat Mahrous

09:40-10:20

Session II: Rectal Cancer Neoadjuvant therapy in rectal cancer

Neoadjuvant therapy in MSI-H rectal cancer
Induction chemotherapy vs consolidation chemotherapy
Short vs long course radiotherapy
Can we omit radiotherapy in selected patients?

Panel: Gerald Prager, Mohammed Alghamdi, Turki Alfayea, Mohammed Bayamin, Waleed Alselwi, Ali Alfakeeh, Mohammed Alqarni

Moderator: Ali Aljubran

10:30-11:00

Satellite symposium (Novartis)

11:00-11:40

Session III: Hepatobiliary cancers Immune therapy in Hepatobiliary cancers

Landmark analysis vs. median survival as endpoints of immunotherapy trials in HCC/BTC
1st line therapyand subsequent therapies in advanced HCC/BTC
Adjuvant therapy in HCC

Panel: Shouki Bazarbashi, Ashwaq Aolayan, Gamal Esmat, Marwan Alhejeeli , Roaa Shafi, Kakil Rasoul, Mervat Mahrous, Kanaan Alshemari

Moderator: Fahad Ibn Shamsah

11:40-12:20

Session IV: Colorectal Cancer Liquid biopsy in early/metastatic CRC: Are we ready to go?

Panel: Gerald Prager, Ali Aljubran, Fahad IbnShamsh, Turki Alfayea, Waleed Alselwi, Ali Alfakeeh, Mohammed Alqarni

Moderator: Mohammed Alghamdi

09:00-9:30

Session I: GU cancers Doublet vs. triplet therapy in hormonal sensitive metastatic prostate cancer

Panel: Hani Elkhatib, Abdullah Alsharm, Faisal Albadainah, Jawaher Ansari, Roula Almufti , Emad Tashkandi, Sakher Abdullah, Fahad Almugbel

Moderator: Mubarak Almansour

09:30-10:00

Session II: GU cancers PARPi in mCRCP : single agent or in combination with novel ADT

Panel: Hani Elkhatib, Mubarak Almansour, Faisal Albadainah, Jawaher Ansari, Roula Almufti , Emad Tashkandi, Fahad Almugbel

Moderator: Abdullah Alsharm

10:10 -10:40

Satellite symposium (Pfizer)

10:40-11:20

Session III: Breast cancer ADCs in advanced breast cancer: current challenges and future prospects

Sequencing of ADCs/cross resistance?
Impact of repeating biopsy?
De-escalation in excellent responders
Monitoring of toxicity

Panel: Esam Murshid, Ahmed Saadeldin, Ahmed Refae, Fadi Farhat, Shadi Alkhayyat, Shereef Elsamany, Atlal Abusanad

Moderator: Ahmed Alwbari

Satellite Symposium (Menarini Stemline)

Session I: Challenges in research methodology

Moderators: Jamal Zekri, Ahmed Alrefae, Shereef Elsamany

19:00 –19:20

Surrogate vs. definitive endpoints

19:20-19:40

Interim analysis: pros/cons

19:40-20:00

Artificial intelligence: impact on oncology research and practice

20:00-20:20

Local research challenges in Saudi Arabia

See full Agenda

Registrations Fees

DEBATES IN ONCOLOGY TICKET

Free

online attendance only